This is the authors' abstract. We don't add key points for this paper.
Difructose dianhydride I synthase/hydrolase (αFFase1) is a member of the family 172 of glycoside hydrolases which catalyzes the reversible transformation of inulobiose into difructose dianhydride I (DFA I). This transformation was hypothesized to go through a double-displacement mechanism formed by a glycosylation step and a cyclization step. During the glycosylation step, E270 protonates the O2 of the α-D-fructofuranosyl group in the subsite –1 (–1 sugar), and E291 attacks the anomeric carbon forming a glycosyl-enzyme intermediate (GEI) and releasing a water molecule. During the cyclization, activated by a complex torsional mechanism, the O1 of the β -D-fructofuranosyl group in the subsite +1 attacks the anomeric carbon, cleaving the glycosyl-E291 bond and transferring a proton to the E270. Using hybrid QM/MM metadynamics methods, we demonstrate the energetic accessibility of the glycosylation + cyclization mechanism for the αFFase1-inulobiose complex. Our simulations show a slightly exothermic global reaction (∆G 0 = –1.3 kcal·mol−1) in good agreement with the experimental inulobiose/DFA I resulting ratios (1:8.9). The ∆G ‡ and ∆G 0 for the glyco- sylation are 12.3 and –2.8 kcal·mol−1. The rate-limiting step is the cyclization with a ∆G ‡ = 15.3 kcal·mol−1. Our study shows that the –1 sugar follows the E5 → E5/4T5 → E3 and E3 → 4E → 4E conformational pathways. Further analysis of the cyclization simulation shows the role of E85, K147, and N226 stabilizing the rotation of the +1 sugar and facilitating the attack of the O1’ to the anomeric carbon.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Geronimo et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: